ClinicalTrials.gg
Not yet recruitingNCT07946185Updated Nov 18, 2026

Pediatric OCD Talus RCT Feasibility

An interventional study of Viable Cartilage Allograft Implantation and Arthroscopic Drilling and Chondroplasty in Osteochondritis Dissecans of Ankle and Joints of Foot, sponsored by Children's Hospital of Eastern Ontario. Not yet recruiting. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Children's Hospital of Eastern Ontario · Not applicable, Interventional, and Treatment

How we know

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

Osteochondritis dissecans (OCD) of the talus is a condition affecting the bone and cartilage of the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and daily activities. Children and adolescents with persistent symptoms or unstable lesions may require surgery when nonsurgical treatments are unsuccessful.

Two surgical approaches used to treat this condition are arthroscopic drilling and chondroplasty, which aim to stimulate healing of the affected bone and cartilage, and viable cartilage allograft implantation, which uses donated cartilage material to repair the damaged area. There is limited evidence comparing these treatments in children and adolescents, and it is not known whether one approach provides better outcomes.

This pilot randomized controlled trial aims to assess the feasibility of conducting a larger study comparing these two surgical treatments in pediatric patients with talar OCD. Approximately 20 participants requiring surgery will be recruited at the Children's Hospital of Eastern Ontario (CHEO) and randomly assigned to receive either viable cartilage allograft implantation (CartiMax®) or arthroscopic drilling and chondroplasty.

The primary objective is to assess the feasibility of recruitment, acceptance of randomization, participant retention, completion of imaging and questionnaires, and adherence to the study procedures. Secondary objectives include exploring differences in ankle pain, function, healing on magnetic resonance imaging (MRI), complications, and the need for additional surgery.

Participants will undergo postoperative rehabilitation according to standard clinical care and will be followed for up to 24 months after surgery.

The findings will help determine whether a larger multicentre randomized trial is feasible and provide preliminary information about healing and recovery following each surgical treatment. This pilot study is not designed to determine which treatment is more effective.

Read the detailed description

Osteochondritis dissecans (OCD) of the talus is a condition that affects the bone and cartilage in the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and everyday activities. Some children and adolescents with this condition require surgery when treatments such as rest, activity restrictions, and immobilization have not improved their symptoms.

Two surgical approaches are available to treat this condition. One involves drilling small holes into the affected bone and smoothing damaged cartilage to encourage healing. The other involves placing donated cartilage material into the damaged area to support cartilage repair. It is not yet known whether one approach leads to better healing and recovery in children and adolescents.

The main purpose of this pilot study is to determine whether it is feasible to conduct a larger study comparing these two surgical treatments. Researchers will assess whether enough patients can be recruited, whether families are willing to accept random assignment to either treatment, and whether participants can complete the required follow-up visits, imaging, and questionnaires.

The study will include approximately 20 children and adolescents who require surgery for osteochondritis dissecans of the talus at the Children's Hospital of Eastern Ontario (CHEO) in Ottawa, Canada. Participants will be randomly assigned, like flipping a coin, to receive one of two surgical treatments:

  • **Viable cartilage allograft:** Surgery to prepare the damaged area and place donated cartilage material (CartiMax®) into the defect.
  • **Arthroscopic drilling and chondroplasty:** Surgery using a small camera and instruments to smooth damaged cartilage and drill into the underlying bone to encourage healing.

All participants will receive the same standard postoperative rehabilitation approach. Follow-up assessments will take place approximately 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery. Researchers will assess ankle pain, function, healing on imaging, return to sports, complications, and whether additional surgery is needed.

The researchers expect this pilot study to help determine whether a larger randomized trial can be successfully conducted. The study will also provide early information about healing and recovery after each treatment. Because this is a small pilot study, it is not designed to determine which surgical treatment is better.

02

Conditions studied

  • Osteochondritis Dissecans of Ankle and Joints of Foot
03

In context

Osteochondritis Dissecans

31 studies on the registry are indexed under Osteochondritis Dissecans; 9 are open to participants now.

This study's planned enrollment of 20 is below the median of 43 across 18 interventional studies indexed under Osteochondritis Dissecans.

Browse Osteochondritis Dissecans studies →

Lead sponsor

Children's Hospital of Eastern Ontario is the lead sponsor of 85 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged ≤ 5 years and ≥ 18 years
  • Patients seen at the CHEO Orthopaedic Sports Medicine Clinic with symptomatic talar OCD requiring surgery
  • Patients that have an unstable lesion on MRI
  • Must be able to complete patient-reported outcome measures in English or French
  • Are willing to be randomized between the two unblinded surgical approaches.
  • Participants must have had failure of non-operative treatment including rest, activity restriction, and six weeks of immobilization.

Exclusion criteria

Exclusion Criteria:

  • Unwillingness to attend follow-up appointments or complete research activities.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Viable Cartilage Allograft (CartiMax)

    Participants undergo arthroscopic lesion preparation followed by implantation of CartiMax viable cartilage allograft into the damaged area of the talus. Standard postoperative rehabilitation is provided.

    Procedure: Viable Cartilage Allograft Implantation

  • Active comparator
    Arthroscopic Drilling and Chondroplasty

    Participants undergo arthroscopic drilling and chondroplasty to remove or smooth unstable cartilage and stimulate healing of the underlying bone. Standard postoperative rehabilitation is provided.

    Procedure: Arthroscopic Drilling and Chondroplasty

Interventions

  • ProcedureViable Cartilage Allograft Implantation

    Participants undergo arthroscopic preparation of the talar osteochondral lesion followed by implantation of CartiMax viable cartilage allograft, consisting of viable cartilage fibers and cartilage allograft matrix. The graft is placed into the cartilage defect to support repair. Participants follow the standard postoperative rehabilitation protocol.

  • ProcedureArthroscopic Drilling and Chondroplasty

    Participants undergo arthroscopic drilling and chondroplasty of the talar osteochondral lesion. Unstable cartilage is removed or smoothed, and small channels are drilled into the affected bone to stimulate healing. Participants follow the standard postoperative rehabilitation protocol.

06

What researchers measure

Primary outcomes

  1. Recruitment Rate

    Number of participants enrolled per year during the recruitment period. Recruitment feasibility will be assessed against a target of at least 10 participants enrolled per year.

    Time frame: 24 months

Secondary outcomes

  1. Questionnaire Completion Rate at 6 Months

    Proportion of randomized participants who complete the required 6-month postoperative pain and ankle function assessments, including the Visual Analogue Scale (VAS) and American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score. The target questionnaire completion rate is at least 80%.

    Time frame: 6 months after surgery

  2. MRI Completion Rate at 6 Months

    Proportion of randomized participants who complete the scheduled 6-month postoperative magnetic resonance imaging (MRI) assessment. The target MRI completion rate is at least 80%.

    Time frame: 6 months after surgery

  3. Participant Retention Rate at 6 Months

    Proportion of randomized participants who remain in the study and complete the 6-month postoperative follow-up assessment. The target retention rate is at least 70%.

    Time frame: 24 months

  4. Randomization Acceptance Rate

    Proportion of eligible patients approached for participation who consent to random assignment to either surgical treatment. The target randomization acceptance rate is at least 80%.

    Time frame: 24 months

  5. Adherence to Randomized Treatment Allocation

    Proportion of randomized participants who undergo their assigned surgical intervention, either viable cartilage allograft implantation or arthroscopic drilling and chondroplasty. Crossovers and deviations from assigned treatment will be documented.

    Time frame: At the time of surgery (assessed up to 1 hour)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Pallamar M, Eder T, Ganger R, Farr S. Surgical treatment of atraumatic osteochondrosis dissecans of the immature talus-Clinical results and prevalence of radiographic joint degeneration after a median follow-up of 72.5 months. Foot Ankle Surg. 2022 Jul;28(5):557-563. doi: 10.1016/j.fas.2021.05.007. Epub 2021 May 17. PubMed 34020882 ↗
  • Jungesblut OD, Berger-Groch J, Hoffmann M, Schroeder M, Krajewski KL, Stuecker R, Rupprecht M. Electromagnetic navigation reduces radiation exposure for retrograde drilling in osteochondrosis dissecans of the talus. BMC Musculoskelet Disord. 2021 Feb 3;22(1):135. doi: 10.1186/s12891-021-04010-4. PubMed 33536008 ↗
  • Porta-Alesandria J, Van Bergen CJA, Masquijo JJ. Evaluation and management of osteochondral lesions of the talus in skeletally immature patients. Acta Ortop Mex. 2022 Nov-Dec;36(6):335-339. PubMed 37669651 ↗
  • Kim HW, Park KB, Kim CW, Lee KY, Park H. Healing Predictors of Conservative Treatment for Juvenile Osteochondritis Dissecans of the Talus. Clin J Sport Med. 2022 Nov 1;32(6):e635-e643. doi: 10.1097/JSM.0000000000001049. Epub 2022 May 27. PubMed 36315829 ↗
  • Li Y, Dong A, Huang Z, Li W, Deng Z. [Advances in the Treatment of Osteochondral Lesions of the Talus]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 20;55(2):273-278. doi: 10.12182/20240360206. Chinese. PubMed 38645844 ↗
  • Nguyen JC, Kan JH, Patel VS, Blankenbaker DG, Rubin DA, Shea KG, Nissen CW, Jaramillo D, Ganley TJ. Osteochondritis dissecans in children: location-dependent differences (part II: ankle and elbow). Pediatr Radiol. 2025 Jun;55(7):1386-1402. doi: 10.1007/s00247-025-06259-6. Epub 2025 May 16. PubMed 40377713 ↗
  • Jorgensen MS, Shah N, Nadwodny J, Skov R, Pujalte GGA. Osteochondritis Dissecans of the Talar Dome and Navicular Bone in an Adolescent Athlete: A Prolonged Clinical Course. Cureus. 2025 May 5;17(5):e83495. doi: 10.7759/cureus.83495. eCollection 2025 May. PubMed 40470399 ↗
  • Mizuo C, Parkman L, Ayazi T, Hu H, Adams A. Osteochondral Lesions of the Talus Treated With Particulated Juvenile Cartilage Allograft in the Active Duty Military Population. Foot Ankle Orthop. 2026 Aug 20;11(3):24730114261471519. doi: 10.1177/24730114261471519. eCollection 2026 Jul. PubMed 42630594 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for Jan 2029, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 18, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Jan 2029
CompletionEst.
Jan 2030
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946185
Lead sponsor
Children's Hospital of Eastern Ontario
Responsible party
Magdalena Tarchala (Orthopedic Surgeon, Children's Hospital of Eastern Ontario) — Principal investigator
First posted
Nov 18, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jan 2029 (estimated)
Completion
Jan 2030 (estimated)
Last update
Nov 18, 2026

Study contacts

Holly Livock Research Manager, MSc.
Contact
hlivock@cheo.on.ca
6137377600 ext. 4120

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion